Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.57
-1.42 (-7.48%)
At close: Nov 5, 2026, 4:00 PM EST
17.18
-0.39 (-2.22%)
After-hours: Nov 5, 2026, 7:55 PM EST
Sarepta Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 472.76 | 801.28 | 1,103 | 428.43 | 966.78 | 2,116 |
Short-Term Investments | 406.02 | 138.37 | 251.78 | 1,248 | 1,023 | - |
Cash & Short-Term Investments | 878.78 | 939.65 | 1,355 | 1,676 | 1,989 | 2,116 |
Cash Growth | 3.26% | -30.64% | -19.18% | -15.74% | -5.98% | 9.15% |
Accounts Receivable | 369.18 | 502.35 | 636.6 | 430.11 | 256.39 | 171.64 |
Other Receivables | - | 17.26 | 15.1 | 6.86 | 5.21 | 0.01 |
Receivables | 369.18 | 519.61 | 651.7 | 436.98 | 261.6 | 171.65 |
Inventory | 876.12 | 914.74 | 749.96 | 322.86 | 203.97 | 186.21 |
Prepaid Expenses | - | 29.24 | 32.89 | 27.64 | 29.64 | 30.31 |
Other Current Assets | 148.82 | 134.69 | 284.13 | 115.61 | 73.28 | 100.06 |
Total Current Assets | 2,273 | 2,538 | 3,073 | 2,579 | 2,558 | 2,604 |
Property, Plant & Equipment | 437 | 470.62 | 488.65 | 357.11 | 244.99 | 236.69 |
Long-Term Investments | 108.82 | 10.57 | 136.87 | 6.53 | 31.32 | 34.89 |
Other Intangible Assets | - | 28.95 | 26.89 | 29.62 | 7.58 | 14.24 |
Long-Term Deferred Tax Assets | - | 2.82 | 2.25 | - | - | - |
Other Long-Term Assets | 347.37 | 298.81 | 235.05 | 291.99 | 286.62 | 258.06 |
Total Assets | 3,166 | 3,350 | 3,963 | 3,265 | 3,128 | 3,148 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 45.7 | 280.84 | 214.44 | 164.92 | 95.88 | 76.74 |
Accrued Expenses | 321.76 | 237.39 | 246.97 | 197.93 | 335.67 | 206.45 |
Current Portion of Long-Term Debt | 157.97 | - | - | 105.48 | - | - |
Current Portion of Leases | - | 11.2 | - | - | 15.49 | - |
Current Income Taxes Payable | - | 4.76 | 17.39 | 13.77 | 12.52 | 0.22 |
Current Unearned Revenue | 104.89 | 443.4 | 130.26 | 50.42 | 89.24 | 89.24 |
Other Current Liabilities | 26.03 | 117.72 | 122.63 | 121.15 | 70.8 | 80.08 |
Total Current Liabilities | 656.35 | 1,095 | 731.68 | 653.66 | 619.6 | 452.73 |
Long-Term Debt | 699.39 | 828.97 | 1,137 | 1,133 | 1,544 | 1,097 |
Long-Term Leases | 195.66 | 199.38 | 192.47 | 140.97 | 57.58 | 41.51 |
Long-Term Unearned Revenue | 83.91 | 83.91 | 325 | 437 | 485 | 574.24 |
Other Long-Term Liabilities | 1.89 | 1.53 | 49.15 | 41.1 | 36.94 | 54.6 |
Total Liabilities | 1,637 | 2,209 | 2,435 | 2,405 | 2,743 | 2,220 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 6,135 | 6,043 | 5,739 | 5,305 | 4,297 | 4,135 |
Retained Earnings | -4,579 | -4,877 | -4,211 | -4,446 | -3,910 | -3,207 |
Treasury Stock | -25.01 | -25.26 | - | - | - | - |
Comprehensive Income & Other | -1.59 | 0.27 | -0.22 | 0.92 | -1.66 | -0.02 |
Shareholders' Equity | 1,529 | 1,141 | 1,528 | 859.34 | 384.95 | 928.01 |
Total Liabilities & Equity | 3,166 | 3,350 | 3,963 | 3,265 | 3,128 | 3,148 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,053 | 1,040 | 1,330 | 1,379 | 1,617 | 1,138 |
Net Cash (Debt) | -174.25 | -99.9 | 25.2 | 297.29 | 372.02 | 977.48 |
Net Cash Growth | - | - | -91.53% | -20.09% | -61.94% | 12.91% |
Net Cash Per Share | -1.65 | -1.00 | 0.23 | 3.22 | 4.25 | 12.03 |
Filing Date Shares Outstanding | 107.24 | 104.99 | 97.03 | 93.86 | 87.98 | 87.15 |
Total Common Shares Outstanding | 107.23 | 104.96 | 96.9 | 93.73 | 87.95 | 87.13 |
Working Capital | 1,617 | 1,443 | 2,342 | 1,926 | 1,938 | 2,151 |
Book Value Per Share | 14.26 | 10.87 | 15.77 | 9.17 | 4.38 | 10.65 |
Tangible Book Value | 1,529 | 1,112 | 1,501 | 829.72 | 377.37 | 913.77 |
Tangible Book Value Per Share | 14.26 | 10.59 | 15.49 | 8.85 | 4.29 | 10.49 |
Land | - | 10.17 | 10.17 | 10.17 | 5.18 | 5.18 |
Buildings | - | 52.23 | 51.18 | 48.06 | 47.94 | 47.61 |
Machinery | - | 152.98 | 141.98 | 118.63 | 102.31 | 75.04 |
Construction In Progress | - | 5.58 | 165.9 | 91.09 | 23.59 | 25.16 |
Leasehold Improvements | - | 349.73 | 155.07 | 99.99 | 97.33 | 103.37 |